The following studies are underway in the late stages of research. We're watching them closely.
October 20, 2020
Anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis
December 20, 2020
Researchers have identified an immune cell in mice that promotes axon regeneration and neuronal survival and could potentially be harnessed as a treatment for brain, spinal cord, and optic nerve damage.
Simple sugar possible therapy for repairing myelin in multiple sclerosis
Mechanisms identified to restore myelin sheaths after injury or in multiple sclerosis
Advances with Long Non-Coding RNAs in Diabetic Peripheral Neuropathy (A peer-reviewed study)
Kolon begins testing gene therapy for neuropathic pain in US
EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain
EC5026 just passed Phase 1a Clinical Trial, Nov 15, 2020: